![Robert More](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert More
Vorsitzender bei
TYRA BIOSCIENCES, INC.
Vermögen: 245 156 $ am 31.12.2025
Profil
Robert J.
More currently works at Affinivax, Inc., as Chairman, Tyra Biosciences, Inc., as Chairman from 2019, Alta Partners Management Co. LP, as Managing Director, Acureon Pharmaceuticals, Inc., as Director, Biotechnology Innovation Organization, as Director, Sirenas LLC, as Director, Nuon Therapeutics, Inc., as Director, Vir Biotechnology, Inc., as Independent Director from 2016, Variant Bio, Inc., as Director, Mbrace Therapeutics, Inc., as Director, Kelonia Therapeutics, Inc., as Director, and Amplitude Therapeutics, Inc., as Director.
Mr. More also formerly worked at Intercept Pharmaceuticals, Inc., as Chairman, TargetRx, Inc., as Director, ESP Pharma, Inc., as Director, Receptor BioLogix, Inc., as Director, AMO Development LLC, as Director, PatientKeeper, Inc., as Director, Achaogen, Inc., as Director, NovaCardia, Inc., as Director, Esprit Pharma, Inc., as Director, Foundation for Innovative New Diagnostics, as Director, Glaukos Corp., as Director from 2001 to 2015, Apnex Medical, Inc., as Director, One Revolution Entertainment LLC, as Director, Cytyc Surgical Products II, Inc., as Director, Carticept Medical, Inc., as Director from 2005 to 2010, Society of Kauffman Fellows, as Director, Oceana Therapeutics, Inc., as Director, Neothetics, Inc., as Director, Moximed, Inc., as Director, Cartiva, Inc., as Director, eGenesis, Inc., as Director, Hangzhou Qihan Biotech Co., Ltd., as Director, Proxima Therapeutics, Inc., as Director, Sienna Biopharmaceuticals, Inc., as Independent Director, Frazier Management LLC, as General Partner from 2008 to 2013, Domain Associates LLC, as Partner from 1996 to 2008, Morphochem, Inc., as Chief Operating Officer, and Bill & Melinda Gates Foundation Trust (Investment Management), as Senior Advisor.
Mr. More received his undergraduate degree in 1989 from Middlebury College and Masters Business Admin degree from the University of Virginia Darden School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC. 0,03 % | 09.06.2025 | 40.656 ( 0,03 % ) | 245 156 $ | 31.12.2025 |
TYRA BIOSCIENCE, INC -.--% | 29.05.2025 | 0 ( -.--% ) | - $ | 31.12.2025 |
Aktive Positionen von Robert More
| Unternehmen | Position | Beginn |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.09.2016 |
| TYRA BIOSCIENCES, INC. | Vorsitzender | 01.03.2019 |
Sirenas LLC
 Sirenas LLC Develops proprietary drug discovery technology | Direktor/Vorstandsmitglied | - |
Affinivax, Inc.
 Affinivax, Inc. Operates as a biotechnology company which develops novel conjugation technology | Vorsitzender | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Kelonia Therapeutics, Inc.
 Kelonia Therapeutics, Inc. Develops genetic medicines | Direktor/Vorstandsmitglied | - |
Mbrace Therapeutics, Inc.
 Mbrace Therapeutics, Inc. Provides drug discovery and development services for cancer treatment | Direktor/Vorstandsmitglied | - |
Variant Bio, Inc.
 Variant Bio, Inc. Develops therapeutics for human generic diversity | Direktor/Vorstandsmitglied | - |
Acureon Pharmaceuticals, Inc.
 Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops & markets therapeutics for infectious diseases | Direktor/Vorstandsmitglied | - |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Ehemalige bekannte Positionen von Robert More
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Robert More
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
100
+
Beziehungen ersten Grades
42
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 42 |
|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States with an EBITDA of USD10 million - USD75 million. The firm focuses on sectors such as science, pharmaceuticals and healthcare services. It participates in mezzanine financing for late private/public opportunities, buyouts, recapitalizations, corporate carve-outs, seed, early and later stage with an investment size of USD50 million - USD400 million. | Finance |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Finance |
TargetRx, Inc.
 TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Commercial Services |
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Health Technology |
Receptor BioLogix, Inc.
 Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Health Technology |
AMO Development LLC
 AMO Development LLC Medical SpecialtiesHealth Technology Designs, develops and manufactures femtosecond laser technology for use in ophthalmology | Health Technology |
PatientKeeper, Inc.
 PatientKeeper, Inc. Packaged SoftwareTechnology Services Provides healthcare applications for physicians | Technology Services |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cardiovascular diseases | Health Technology |
Esprit Pharma, Inc.
 Esprit Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Provides diagnostic tests for poor people | Health Services |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Acureon Pharmaceuticals, Inc.
Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops & markets therapeutics for infectious diseases | Retail Trade |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Apnex Medical, Inc.
 Apnex Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets medical devices | Health Technology |
One Revolution Entertainment LLC | |
Sirenas LLC
Sirenas LLC Develops proprietary drug discovery technology | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Finance |
Morphochem, Inc.
 Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytyc Surgical Products II, Inc.
 Cytyc Surgical Products II, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical devices | Health Technology |
Carticept Medical, Inc.
 Carticept Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Health Technology |
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Health Technology |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services Operates as a network of venture capitalists | Commercial Services |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and medical devices | Health Technology |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic | Health Technology |
Moximed, Inc.
 Moximed, Inc. Medical SpecialtiesHealth Technology Develops medical device treatments | Health Technology |
Cartiva, Inc.
 Cartiva, Inc. Develops and manufactures medical devices | |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Functions as a College/University | |
Bill & Melinda Gates Foundation Trust (Investment Management)
 Bill & Melinda Gates Foundation Trust (Investment Management) Foundation Trust-IM holds the endowment, including the annual installments of Warren Buffett’s gift, and funds the foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed, as it has been for almost three decades, by a team of outside investment managers. The Trust invests in undistributed assets, with the exclusive goal of maximizing the return on investment. Investments include companies that have been criticized for worsening poverty in the same developing countries where the foundation is attempting to relieve poverty. The majority of the trust's assets are invested in government and corporate bonds, with additional holdings in commercial paper and other short-term debt securities. The trust engages in substantial foreign currency transactions, options and futures trading and lending out of securities. | |
Affinivax, Inc.
Affinivax, Inc. Operates as a biotechnology company which develops novel conjugation technology | |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | |
eGenesis, Inc.
 eGenesis, Inc. Operates as a biotechnology company that provides organs and cells transplantation services | |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. Develops cures and treatments drug for viral & bacterial diseases | |
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Provides healthcare services | |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | |
Variant Bio, Inc.
Variant Bio, Inc. Develops therapeutics for human generic diversity | |
Proxima Therapeutics, Inc.
 Proxima Therapeutics, Inc. Develops radiation delivery systems for the treatment of solid cancerous tumor | |
Mbrace Therapeutics, Inc.
Mbrace Therapeutics, Inc. Provides drug discovery and development services for cancer treatment | |
Kelonia Therapeutics, Inc.
Kelonia Therapeutics, Inc. Develops genetic medicines | |
Amplitude Therapeutics, Inc.
 Amplitude Therapeutics, Inc. Operates as a biotechnology company focusing on developing the of medicine |
